Partial Remission Definition: Validation based on the insulin dose-adjusted HbA1c (IDAA1C) in 129 Danish Children with New-Onset Type 1 Diabetes

Pediatric Diabetes

Volumn 15, Issue 7, 2014, Pages 469-476

  Max Andersen, Marie Louise C ^a   Hougaard, Philip ^b   Pörksen, Sven ^a   Nielsen, Lotte B ^a   Fredheim, Siri ^a   Svensson, Jannet ^a   Thomsen, Jane ^c   Vikre Jørgensen, Jennifer ^d   Hertel, Thomas ^e   Petersen, Jacob S ^f   Hansen, Lars ^a   Mortensen, Henrik B ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c KOLDING HOSPITAL   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

^f NOVO NORDISK A S   (Denmark)

Author keywords

C peptide; Children; Definition for partial remission; Diabetes mellitus; Type 1

Indexed keywords

C PEPTIDE; HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; CHILD; DANISH CITIZEN; FEMALE; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PARTIAL REMISSION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; REMISSION; SENSITIVITY AND SPECIFICITY; AGE; BLOOD; CLINICAL TRIAL; COHORT ANALYSIS; DENMARK; DIABETES MELLITUS, TYPE 1; DIAGNOSTIC USE; DIFFERENTIAL DIAGNOSIS; DRUG EFFECTS; HYPERGLYCEMIA; INSULIN RESISTANCE; METABOLISM; MULTICENTER STUDY; PANCREAS ISLET BETA CELL; PREDIABETIC STATE; PRESCHOOL CHILD; SECRETION (PROCESS); VALIDATION STUDY;

ADOLESCENT; AGE FACTORS; C-PEPTIDE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DENMARK; DIABETES MELLITUS, TYPE 1; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INFANT; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; PREDIABETIC STATE; REMISSION INDUCTION; SENSITIVITY AND SPECIFICITY;

EID: 84907943364     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12208     Document Type: Article

References (23)

1. Akirav E, Kushner JA, Herold KC. Beta-cell mass and type 1 diabetes: going, going, gone? Diabetes 2008: 57: 2883-2888.
2. Pescovitz MD, Greenbaum CJ, Bundy B et al. The T: B-lymphocyte depletion with rituximab and beta-cell function: two-year results. Diabetes Care 2014: 37: 453-459.
3. Orban T, Bundy B, Becker DJ et al. Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: follow-up 1 year after cessation of treatment. Diabetes Care 2014: 37: 1069-1075.
4. The Diabetes Control and Complications Trial Research Group. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. Diabetes 1996: 45: 1289-1298.
5. The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 1997: 46: 271-286.
6. Komulainen J, Lounamaa R, Knip M, Kaprio EA, Akerblom HK. Ketoacidosis at the diagnosis of type 1 (insulin dependent) diabetes mellitus is related to poor residual beta cell functionChildhood Diabetes in Finland Study Group. Arch Dis Child 1996: 75: 410-415.
7. Ortqvist E, Björk E, Wallensteen M, Ludvigsson J et al. Temporary preservation of beta-cell function by diazoxide treatment in childhood type 1 diabetes. Diabetes Care 2004: 27: 2191-2197.
8. Schölin A, Nyström L, Arnqvist H et al. Proinsulin/C-peptide ratio, glucagon and remission in new-onset type 1 diabetes mellitus in young adults. Diabet Med 2011: 28: 156-161.
9. Buyukgebiz A, Cemeroglu AP, Bober E, Mohn A, Chiarelli F. Factors influencing remission phase in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2001: 14: 1585-1596.
10. Mortensen HB, Hougaard P, Swift P et al. New definition for the partial remission period in children and adolescents with type 1 diabetes. Diabetes Care 2009: 32: 1384-1390.
11. Mortensen HB, Swift PGF, Holl RW et al. Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis. Pediatr Diabetes 2010: 11: 218-226.
12. Andersen ML, Vaziri-Sani F, Delli A et al. Association between autoantibodies to the Arginine variant of the Zinc transporter 8 (ZnT8) and stimulated C-peptide levels in Danish children and adolescents with newly diagnosed type 1 diabetes. Pediatr Diabetes 2012: 13: 454-462.
13. Andersen MLM, Rasmussen MA, Pörksen S et al. Complex multi-block analysis identifies new immunologic and genetic disease progression patterns associated with the residual beta-cell function 1 year after diagnosis of type 1 diabetes. PLoS One 2013: 8: 1-8.
14. The Diabetes Control and Complications Trial Research Group. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the Diabetes Control and Complications Trial. Ann Intern Med 1998: 128: 517-523.
15. Seshan VE, Gönen M, Begg CB. Comparing ROC curves derived from regression models. Stat Med 2013: 32: 1483-1493.
16. Caprio S, Plewe G, Diamond MP, Simonson DC et al. Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity. J Pediatr 1989: 114: 963-967.
17. Smith CP, Archibald HR, Thomas JM et al. Basal and stimulated insulin levels rise with advancing puberty. Dev Biol 1987: 28: 7-14.
18. Jeffery AN, Metcalf BS, Hosking J, Streeter AJ, Voss LD, Wilkin TJ. Age before stage: insulin resistance rises before the onset of puberty: a 9-year longitudinal study (EarlyBird 26). Diabetes Care 2012: 35: 536-541.
19. Neylon OM, White M, ÓConnell MA, Cameron FJ. Insulin-dose-adjusted HbA1c-defined partial remission phase in a paediatric population-when is the honeymoon over? Diabet Med 2013: 30: 627-628.
20. Bowden SA, Duck MM, Hoffman RP. Young children (<5-yr) and adolescents (>12-yr) with type 1 diabetes mellitus have low rate of partial remission: diabetic ketoacidosis is an important risk factor. Pediatr Diabetes 2008: 9: 197-201.
21. Nimri R, Phillip M, Shalitin S. Children diagnosed with diabetes during infancy have unique clinical characteristics. Horm Res Paediatr 2007: 67: 263-267.
22. Dost A, Herbst A, Kintzel K et al. Shorter remission period in young versus older children with diabetes mellitus type 1. Exp Clin Endocrinol Diabetes 2007: 115: 33-37.
23. Chase HP, MacKenzie TA, Burdick J et al. Redefining the clinical remission period in children with type 1 diabetes. Pediatr Diabetes 2004: 5: 16-19.